← Back to headlines
FibroBiologics Prices Unit Offering and Announces Reverse Stock Split
FibroBiologics has priced its combined unit offering at $4.40 and announced a 1-for-20 reverse stock split, aiming to regain compliance with Nasdaq listing requirements.
30 Mar, 08:29 — 30 Mar, 08:29
Sources
Showing 1 of 1 sources
